1/ The FDA has just approved the marketing of Lumipulse G test, which uses pTAU217/A𝛃42 as the first blood test for early detection of Alzheimer disease in people over 55, showing symptoms for the disease.
1/ The FDA has just approved the marketing of Lumipulse G test, which uses pTAU217/A𝛃42 as the first blood test for early detection of Alzheimer disease in people over 55, showing symptoms for the disease.